Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study (2021)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidade: FMRP
- DOI: 10.1590/1516-4446-2020-1416
- Subjects: COCAÍNA; CANABINOIDES; TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS; DEPENDENTES QUÍMICOS; MÉTODO DUPLO-CEGO
- Keywords: Crack-cocaine; Craving; Cannabidiol; Dependence
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Psychiatry
- ISSN: 1809-452X
- Volume/Número/Paginação/Ano: v. 43, n. 5 , p.467-476, 2021
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
GAYA, Carolina de Meneses et al. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study. Brazilian Journal of Psychiatry, v. 43, n. 5 , p. 467-476, 2021Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2020-1416. Acesso em: 16 mar. 2026. -
APA
Gaya, C. de M., Crippa, J. A. de S., Hallak, J. E. C., Miguel, A. Q., Laranjeira, R., Bressan, R. A., et al. (2021). Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study. Brazilian Journal of Psychiatry, 43( 5 ), 467-476. doi:10.1590/1516-4446-2020-1416 -
NLM
Gaya C de M, Crippa JA de S, Hallak JEC, Miguel AQ, Laranjeira R, Bressan RA, Zuardi AW, Lacerda ALT. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5 ): 467-476.[citado 2026 mar. 16 ] Available from: https://doi.org/10.1590/1516-4446-2020-1416 -
Vancouver
Gaya C de M, Crippa JA de S, Hallak JEC, Miguel AQ, Laranjeira R, Bressan RA, Zuardi AW, Lacerda ALT. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5 ): 467-476.[citado 2026 mar. 16 ] Available from: https://doi.org/10.1590/1516-4446-2020-1416 - Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003113788.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
